Selling semaglutide in the UK: the legal picture, explained plainly

What makes selling semaglutide illegal without the right framework?

Semaglutide (whether that's Wegovy (licensed for weight management) or Ozempic (licensed for type 2 diabetes)) sits in the Prescription-Only Medicine category under UK law. The Human Medicines Regulations 2012 prohibit any supply of a POM to a member of the public unless it comes from a registered pharmacy against a valid prescription written by a qualified prescriber.

That means an individual cannot legally sell semaglutide to a friend, list it on a marketplace site, or hand it over for cash. A commercial website cannot dispatch it without a prescription and a GPhC-registered dispensing pharmacy behind the operation. The restriction exists precisely because semaglutide affects gastric emptying, blood sugar, pancreatic function and other systems that require clinical oversight. Getting the dosing wrong (or using a counterfeit) can cause serious harm. The MHRA's Yellow Card scheme is the place to report any seller that appears to be operating outside these boundaries.

If you want a fuller breakdown of where the line sits legally, our page on whether selling semaglutide is illegal covers the specific legislation in detail.

The counterfeit problem: why unverified sellers carry real risk

Enforcement data from 2025 is stark. The MHRA seized roughly 20 million doses of illegally traded weight-loss medicines, with a street value of around £45 million, and raided the UK's first illicit manufacturing site producing counterfeit tirzepatide pens. Earlier MHRA warnings from October 2023 documented fake "Ozempic" and "Saxenda" pens that had been filled with insulin, a substitution that put people in hospital.

Counterfeit pens are not distinguishable by eye. They can carry the right branding, the right-looking pen mechanism, and still contain the wrong substance at the wrong concentration. The sellers offering them frequently use social media, messaging apps, and marketplace platforms precisely because those channels are harder to regulate. Prices that sit well below typical private market rates are one of the clearest warning signs.

One quick check you can do in under a minute: search the seller's pharmacy name or registration number on the GPhC register. A legitimate UK online pharmacy will appear there. If the seller has no GPhC registration, stop. That single check catches a significant share of illegal operations before any money changes hands.

What legitimate supply actually looks like, and where semaglutide sits in it

Semaglutide for weight loss is licensed in the UK as Wegovy, an injectable weekly pen. A separate oral tablet formulation received MHRA approval in June 2026, the first oral GLP-1 medicine licensed for weight management in the UK. Neither can be accessed without a prescription following a clinical assessment. The NHS makes Wegovy available through specialist weight management services under NICE guidance (TA875), though waiting lists are commonly long. Private routes through regulated online pharmacies are the alternative.

A legitimate private route looks like this: a prescriber reviews your health information; identity and weight are verified; a prescription is issued only if you're clinically suitable; a GPhC-registered pharmacy dispenses and sends the medicine directly to you. No step in that chain can be bypassed. Our semaglutide overview explains both the evidence base and the full licensed pathway. You can also read more about who can legally sell semaglutide and whether selling it privately is permitted.

For context on what private treatment costs through regulated services, the Wegovy pricing page sets out what a transparent, all-included price covers.

The decision this keyword is really asking about

Most people searching around "selling semaglutide" are asking one of two things: is the seller they've found legitimate, or is there a cheaper route that bypasses the usual checks? The honest answer to both is the same one. For a prescription medicine, the clinical assessment is not a bureaucratic hoop, it's what keeps the medicine safe. Semaglutide interacts with other medicines, it's contraindicated in certain conditions, and it requires gradual dose increases to manage side effects. A seller who skips all of that is not offering a shortcut; they're removing the safeguard.

The MHRA's published guidance on GLP-1 medicines makes clear that these are not assessed for quick or cosmetic weight loss and that supply outside the licensed framework is both illegal and dangerous. If you're considering semaglutide for weight management, the right starting point is a conversation with a qualified prescriber, not a marketplace listing. Our weight-loss treatment overview outlines what that process involves, and our FAQs page answers the questions people most often bring to that first consultation.

If you'd like to explore whether semaglutide is clinically appropriate for you, speak to our prescribers, the consultation is free, and a real clinician reads your answers the same day.